SGLT2 Inhibitors as First-line Therapy for Diabetes With CVD? SGLT2 Inhibitors as First-line Therapy for Diabetes With CVD?

An expert argues case for SGLT2 inhibitors as first-line therapy for patients with type 2 diabetes and CVD, but is he fighting a losing battle? As even he concedes cost is currently a major barrier.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news